GKOS vs TDG · rev $336.2M vs P/E 41, rev $8.83B
Glaukos Corp (GKOS) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported GKOS revenue for 2026-06-30 was $336.2M. Net income was -$38.2M. GKOS currently screens at market cap $7.63B.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
GKOS currently screens at market cap $7.63B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the GKOS and TDG stock pages for the full models.
Not investment advice.